Results of the LEVEL Study

Show Description +

The LEVEL Study assessed the efficacy of Macugen (pegaptanib sodium injection) as maintenance therapy in neovascular age-related macular degeneration (AMD). Thomas R. Friberg, MD, an investigator in the LEVEL study, explains the clinical findings and the impact on AMD treamtment.

Posted: 5/19/2010

Results of the LEVEL Study

The LEVEL Study assessed the efficacy of Macugen (pegaptanib sodium injection) as maintenance therapy in neovascular age-related macular degeneration (AMD). Thomas R. Friberg, MD, an investigator in the LEVEL study, explains the clinical findings and the impact on AMD treamtment.

Posted: 5/19/2010

Please log in to leave a comment.

More in Retina

Trends in PDR Treatments

Maria Berrocal, MD; and Katherine Talcott, MD

GLP-1 Use and AMD Risk

Barton Blackorby, MD, Katharine Talcott, MD, and Hong-Uyen Hua, MD

Bilateral Vitreomacular Traction

Frédéric Aissani, MD